Pulished Date October, 2018
ID: 192
Share on
Share on

Market Data Forecast report predicts that, the ‘Global Minimally Invasive Surgical Instruments Market’ is predicted to reach $ 18.16 billion by 2021 with a CAGR of 10.19%

Pulished: October, 2018
ID: 192
Pages: 0

The Global Minimally Invasive Surgical Instruments Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, and Competitive Landscape etc. According to the report, the Global Minimally Invasive Surgical Instruments Market is estimated to be $ 13.57 billion in 2018 and predicted to reach $ 22.04 billion by 2023 with a CAGR of 10.19%. The market is segmented by product (handheld instruments, Electrosurgical Devices,  Inflation Systems, Guiding Devices, Cutter Instruments, and Auxiliary Instruments), application (Orthopedic Surgery, Gastrointestinal Surgery, Cardiothoracic Surgery, Urological Surgery, Cosmetic/Bariatric Surgery, Gynecological Surgery, Vascular Surgery, and other applications), and end users (Private Hospitals & Surgical Clinics, Government Hospitals, and Academic & Research Institutes). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Growth of global minimally invasive surgical instruments market is attributed to rising number of surgeries, increasing number of lifestyle disorders, and technological advancements. Moreover, the key benefits offered by minimally invasive surgeries such as reduction in healthcare cost (reduced long time hospital admission & unnecessary travel costs) and early recovery from surgery as compared to traditional open surgeries are further driving the growth of global minimally invasive surgical instruments market. However, certain limitations pertaining to minimally invasive surgery (such as not suitable for high body mass index, skin adhesions conditions) and risks & complications associated with this surgery (such as complications of anesthesia, bleeding) are some of the factors restraining the growth of global minimally invasive surgical instruments market.

North America is estimated to account for the largest market share of 34.2% of global minimally invasive surgical instruments market owing to Increasing aging population, growing number of surgical procedures, rising government investments, high prevalence rate of lifestyle disorders, and increasing incidence of bone disorders (such as osteoporosis arthritis) & spine injuries. Asia-Pacific region is estimated to be the fastest growing segment with a CAGR of 12.20% during forecast period 2018-2023. High growth of the market in this region is due to Presence of huge population undergoing surgeries, increasing number of geriatric population, rising awareness among the physicians about advanced surgical technologies & instruments, increasing demand for minimally invasive surgical instruments, and growing government initiative to reduce the healthcare expenditure.

The key players in global minimally invasive surgical instruments market such as, Medtronic plc (Ireland), Ethicon, Inc. (U.S.), Aesculap, Inc. (Germany), Stryker Corporation (U.S.), Smith & Nephew (U.K.), ConMed Corporation (U.S.), Abbott Laboratories (U.S.), Applied Biomedical Resources Corporation (U.S.), Microline Surgical (Japan), and Zimmer Biomet (U.S.).

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-minimally-invasive-surgical-instruments-market-215/ ” and checkout our recent reports in the Medical Devices [CI2] category at “http://www.marketdataforecast.com/research-reports/healthcare/medical-devices-2/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

 

LICENCE TYPE

$ 1234 0

Clients
clients
clients
clients
clients
clients
clients

Research Areas